DB
JAZZ icon

Danske Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Danske Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.09M Buy
+21,119
New +$4.63M 0.01% 523
2026
Q1 		– Sell
-400
Closed -$68K – 1369
2025
Q4 		$68K Buy
400
+100
+33% +$15.3K ﹤0.01% 888
2025
Q3 		$39.5K Sell
300
-58
-16% -$6.96K ﹤0.01% 1064
2025
Q2 		$38K Sell
358
-36,646
-99% -$3.98M ﹤0.01% 1090
2025
Q1 		$4.59M Buy
37,004
+20,709
+127% +$2.7M 0.01% 554
2024
Q4 		$2.01M Sell
16,295
-5,656
-26% -$667K 0.01% 656
2024
Q3 		$2.45M Buy
21,951
+13,051
+147% +$1.43M 0.01% 624
2024
Q2 		$950K Sell
8,900
-39,058
-81% -$4.29M ﹤0.01% 784
2024
Q1 		$5.78M Buy
+47,958
New +$5.87M 0.02% 544

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Danske Bank's JAZZ Position: Q2 2026 in Review

Danske Bank opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 21,119 shares worth $5.09M. The stake represents 0.01% of the portfolio and ranks #523 among its holdings. This is a return to the name: Danske Bank previously reported a position in JAZZ as recently as Q4 2025.

Danske Bank first reported a position in JAZZ in Q1 2024 and has held it in 9 quarters since. The position peaked at $5.78M in Q1 2024. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Danske Bank held 21,119 shares of Jazz Pharmaceuticals worth $5.09M as of Q2 2026.
  • Jazz Pharmaceuticals was a new Danske Bank position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.01% of Danske Bank's portfolio in Q2 2026, its #523 holding.
  • Danske Bank first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Danske Bank's Jazz Pharmaceuticals position peaked at $5.78M in Q1 2024.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.